Lipid nanoparticles (LNPs) act as carriers for mRNA and CRISPR payloads across a wide range of therapeutic applications, from cancer to inflammatory and genetic diseases. The same delivery system used ...
Simple 'cocktail' of amino acids dramatically boosts power of mRNA therapies and CRISPR gene editing
Lipid nanoparticles, or LNPs, best known as the delivery vehicle for the COVID-19 mRNA vaccines received by billions of people, are now at the center of a much larger medical revolution. Researchers ...
Artist's rendering of a lipid nanoparticle (blue spherical shape at left) supplemented by amino acids (depicted as chemical compounds) fusing with the cell membrane (red) to deliver therapeutic cargo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results